ProductsPricingFree Market DashboardMarket News FeedScannerChartsHeatmapMarket SectorsTrack RecordMAD AcademyMCP Connector

Axsome Therapeutics, Inc (AXSM)

Nasdaq · Common stock · Pharmaceutical Preparations

$157.40-2.18 (-1.37%)

As of Oct 21, 2:16 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.

Follow AXSM in real time

Real-time quotes, Pro Charting, the scanner and the alert feed on AXSM and every other US listing.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Or open the free AXSM chart →

AXSM at a glance

Key statistics

$8.36B

Market capitalization

Previous close
$159.58
Open
$159.70
Day range
$157.03 – $161.43
Volume
265.0K
Average volume (30 sessions)
823.6K
Shares outstanding
52.38M
Earnings per share
$(3.66)
Price / book
100.3
Price / sales
10.8
Beta (1 year, vs SPY)
0.60

Where the price sits in its year

52-week range

25% of the range

Below the 52-week high
-39.5%
Above the 52-week low
+27.4%

Completed sessions through Oct 20, 2026

Technical snapshot

Below its 50-day and 200-day averages

20-day average
$174.60-8.6%
50-day average
$195.58-18.4%
200-day average
$200.35-20.3%
RSI (14)29.1

In the band below 30 that convention calls oversold. Weak trends can stay there for weeks.

+2.1%

1 week

-22.3%

1 month

-33.4%

3 months

-12.6%

Year to date

+24.7%

1 year

Price change over each window, from completed sessions. Past performance does not indicate future results.

Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.

The member platform, in real time

What members do with AXSM

From the public news wire

AXSM headlines

Market news →

SEC Form 4, most recent first

Insider filings

How to read these →
  • Jacobson Mark L.

    −10.0K

    Chief Operating Officer · Option exercise

    · Sep 3, 2026

  • Jacobson Mark L.

    +10.0K

    Chief Operating Officer · Option exercise

    $129.50K · Sep 3, 2026

  • Jacobson Mark L.

    −10.0K

    Chief Operating Officer · Open-market sale

    $2.09M · Sep 3, 2026

  • TABUTEAU HERRIOT

    −4.7K

    Chief Executive Officer, Director, 10% owner · Open-market sale

    $997.01K · Aug 6, 2026

  • TABUTEAU HERRIOT

    +4.7K

    Chief Executive Officer, Director, 10% owner · Option exercise

    $23.07K · Aug 6, 2026

  • TABUTEAU HERRIOT

    −45.0K

    Chief Executive Officer, Director, 10% owner · Open-market sale

    $9.54M · Aug 5, 2026

  • TABUTEAU HERRIOT

    +45.0K

    Chief Executive Officer, Director, 10% owner · Option exercise

    $222.77K · Aug 5, 2026

  • TABUTEAU HERRIOT

    −4.7K

    Chief Executive Officer, Director, 10% owner · Option exercise

    · Aug 6, 2026

About Axsome Therapeutics, Inc

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Exchange
Nasdaq
Security
Common stock
Industry
Pharmaceutical Preparations
Headquarters
New York, NY
Employees
925
Listed since
Nov 19, 2015
Website
axsome.com
Educational content only. MadStockAlerts provides market commentary, research, and educational content. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security. Trading and investing involve substantial risk, including loss of capital. See the Risk Disclosure and Customer Agreement.

Pick the desk that fits how you trade

Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.